# IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis

> **NCT05372003** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 7 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Dupilumab
- **OTHER:** Photo therapy

## Key facts

- **NCT ID:** NCT05372003
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-09
- **Primary completion:** 2024-02-23
- **Final completion:** 2024-02-23
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05372003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05372003, "IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05372003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*